30 completed, 7 terminated, 6 unknown, 1 enrolling by invitation. 46 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 46 | Completed 30, Terminated 7, Unknown 6, Enrolling by invitation 1, Recruiting 1, Withdrawn 1 |
Follow CellCept: new trials by email Literature Review of CellCept trials Research Report on CellCept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial. Mycophenolate Mofetil (MMF) Maintenance Group, Mycophenolate Mofetil (MMF) Withdrawal Group - Kidney Transplantation, Mycophenolate Mofetil | Phase 4 | Recruiting | Mayo Clinic | 350 | 2025-06-13 | 2026-03-20 |
| Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy Mycophenolate Mofetil, Tacrolimus - Autoimmune Hepatitis | Phase 4 | Unknown | Leiden University Medical Center | 86 | 2022-01-19 | 2022-02-03 |
| Belatacept With Early Steroid Withdrawal rATG and Everolimus in Renal Transplantation (BETTER Trial) Belatacept, Everolimus, mycophenolate mofetil - Kidney Transplant Rejection | Phase 4 | Unknown | University of Cincinnati | 120 | 2021-04-09 | 2021-04-19 |
| Veloxis de Novo Kidney Transplant ECSWD Tacrolimus Extended Release Oral Tablet [Envarsus], Mycophenolate Mofetil, Mycophenolic Acid Oral Product - Kidney Transplantation, Immunosuppression | Phase 4 | Unknown | Simon Tremblay, PharmD, PhD | 60 | 2019-06-21 | 2020-05-13 |
| Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects Budesonide, Tacrolimus（FK506）, Mycophenolate Mofetil - Acute Cellular Graft Rejection, Liver Transplant Rejection | Phase 4 | Withdrawn | Montefiore Medical Center | 2019-01-01 | 2019-09-23 | |
| Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients Tacrolimus Extended Release Capsule, Mycophenolate mofetil, Prednisone - Immunosuppression | Phase 4 | Completed | Medical University of South Carolina | 25 | 2017-05-05 | 2019-12-26 |
| Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants Everolimus, Mycophenolate mofetil, Tacrolimus - Hypertrophy, Left Ventricular | Phase 4 | Completed | Edoardo Melilli | 20 | 2016-11-01 | 2021-01-08 |
| Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation Everolimus, Mycophenolic Acid - Kidney Transplant Rejection, Gastrointestinal Disorder, Functional | Phase 4 | Terminated | Washington University School of Medicine | 1 | 2016-11-01 | 2020-08-10 |
| ACTHar in the Treatment of Lupus Nephritis CellCept, ACTHar gel - Lupus Nephritis | Phase 4 | Terminated | Columbia University | 8 | 2014-10-01 | 2025-03-07 |
| Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy Astagraf XL, Prograf, Mycophenolate mofetil - End Stage Renal Disease | Phase 4 | Completed | University of Cincinnati | 26 | 2014-05-01 | 2015-05-12 |
| Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients Everolimus, Mycophenolate mofetil, Tacrolimus - Drug Interaction Potentiation | Phase 4 | Completed | National Taiwan University Hospital | 14 | 2014-04-01 | 2019-07-24 |
| Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer Everolimus, Tacrolimus, Myfortic - Carcinoma, Hepatocellular | Phase 4 | Enrolling by invitation | Baylor Research Institute | 336 | 2014-03-01 | 2026-01-27 |
| Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients Everolimus, Tacrolimus, Mycophenolic acid - Kidney; Complications, Allograft | Phase 4 | Unknown | Seoul St. Mary's Hospital | 234 | 2013-03-01 | 2014-09-25 |
| Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients Everolimus, Mycophenolic acid dose reduction - BK Virus Infection | Phase 4 | Completed | University of California, San Francisco | 40 | 2012-09-01 | 2016-08-15 |
| A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus. Advagraf, Mycophenolate Mofetil, Sirolimus - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 853 | 2011-03-08 | 2024-10-31 |
| A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids Advagraf, Mycophenolate Mofetil, Simulect - Kidney Transplantation | Phase 4 | Completed | Astellas Pharma Inc | 1166 | 2011-01-22 | 2024-11-01 |
| Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV) Mycophenolate to sirolimus switch - Hepatitis C | Phase 4 | Completed | London Health Sciences Centre | 11 | 2010-06-01 | 2015-02-26 |
| Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation mycophenolate mofetil - Acute Rejection of Renal Transplant | Phase 4 | Completed | Nova Scotia Health Authority | 40 | 2010-02-01 | 2012-08-09 |
| A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients MMF, EC-MPS, Prednisone - Kidney Transplantation | Phase 4 | Completed | Hoffmann-La Roche | 23 | 2009-11-01 | 2015-08-27 |
| Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis tacrolimus, tacrolimus and mycophenolate mofetil - Glomerulonephritis, Membranous | Phase 4 | Completed | Imperial College Healthcare NHS Trust | 40 | 2009-03-03 | 2019-12-12 |
Showing 20 of 46. Sign in to see all of them.
Diabetes Mellitus (2) · Kidney Failure, Chronic (2) · Lupus Nephritis (2) · Renal Insufficiency (2) · Acute Kidney Injury (1) · Atherosclerosis (1) · Carcinoma, Hepatocellular (1) · Delayed Graft Function (1) · Diabetes Mellitus, Type 1 (1) · End Stage Liver Disease (1) · Gastrointestinal Diseases (1) · Glomerulonephritis (1) · Glomerulonephritis, Membranous (1) · Hepatitis C (1) · Hepatitis, Autoimmune (1)
Astellas Pharma Inc (6) · Hoffmann-La Roche (6) · Mayo Clinic (3) · University of Cincinnati (2) · University of Pennsylvania (2) · Baylor College of Medicine (1) · Baylor Research Institute (1) · Columbia University (1) · Edoardo Melilli (1) · Erasmus Medical Center (1) · Fundacion Investigacion y Desarrollo (1) · Guy's and St Thomas' NHS Foundation Trust (1) · Imperial College Healthcare NHS Trust (1) · Institute for Clinical and Experimental Medicine (1) · Leiden University Medical Center (1)
United States (19) · Germany (7) · Canada (6) · Spain (6) · China (4) · France (4) · Netherlands (4) · Australia (3) · Belgium (3) · Czechia (3) · Poland (3) · South Korea (3) · Switzerland (3) · Taiwan (3) · United Kingdom (3)
Mark D. Stegall, M.D. (2) · Allison Webber, MD (1) · Anca D Askanase, MD, MPH (1) · Bart van Hoek (1) · Bryce A Kiberd, MD (1) · Christian Hugo, Prof. Dr. (1) · Chul-Woo Yang, MD (1) · David P D'Cruz, MD, FRCP (1) · Edoardo Melilli, MD (1) · Eulalia Roig, Cardiologist (1)
PMID 39382091, PMID 16468960, PMID 18431244, PMID 18497677, PMID 18946341, PMID 19307792, PMID 19494809, PMID 19714613, PMID 19926370, PMID 20124953, PMID 20600032, PMID 20670958, PMID 21401720, PMID 23007746, PMID 23423269, PMID 25083614, PMID 25550339, PMID 26465152, PMID 27547871, PMID 27871759, PMID 28342282, PMID 31029086, PMID 31492152, PMID 31561278, PMID 32448782, PMID 34778952, PMID 37391381, PMID 38233878
2008 (1), 2009 (1)